Section 1 Short title
This Act may be cited as the “Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023”.
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023
AN ACT
To amend title XI of the Public Health Service Act to reauthorize the program providing for sickle cell disease and other heritable blood disorders research, surveillance, prevention, and treatment.
Sec. 2 Reauthorization of sickle cell disease and other heritable blood disorders research, surveillance, prevention, and treatment
Section 1106(b) of the Public Health Service Act (42 U.S.C. 300b–5(b)) is amended—
in paragraph (3)(A), by inserting “, grant, or cooperative agreement” after “contract”; and
in paragraph (6), by striking “$4,455,000 for each of fiscal years 2019 through 2023” and inserting “$8,205,000 for each of fiscal years 2024 through 2028”.